Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,967.38
(
1.18%
)
US TECH 100
25,135.20
(
1.78%
)
Dow Jones
48,535.99
(
0.66%
)
Brent Oil
92.69
(
-2.91%
)
Bitcoin
74,133.83
(
-0.49%
)
News Focus
News Focus
Post# of 236541
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Learning53

Send PM Follow Ignore
Followers 32
Posts 1622
Boards Moderated 0
Alias Born 10/06/2015

Learning53

Re: HyGro post# 202253

Wednesday, 02/02/2022 1:41:19 AM

Wednesday, February 02, 2022 1:41:19 AM

Post# of 236541
"Judged by Trials" - Was Amarex "onboard" to thwart those trials? Can't help thinking it was just a clever way of "putting a sharp pebble in the CytoDyn shoe."

A COMPETENT CRO or one that wasn't embedded to "thwart progress" - would have noticed the age imbalance in the CD12, or how about some of the other trial design flaws that have CONSTANTLY impeded CytoDyn's progress?

But, those days are, fortunately past!

GO SIDLEY! "Squeeeeeeeeeeeeeeeeeeeeeeeeze"



Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYDY News
More CYDY News